PVI Durability After PFA or RFA in Persistent-AF
JACC: Clinical Electrophysiology · 2026
DOI: 10.1016/j.jacep.2026.04.027 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2026. Verfasst von Oskar M Galuszka und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pulmonary Veins, Catheter Ablation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biosense Webster Inc.
Abstract (Originalsprache)
BACKGROUND: Durable pulmonary vein isolation (PVI) is the primary objective of atrial fibrillation (AF) ablation, yet reconnections are common and non-PV mechanisms may drive recurrence in persistent AF. OBJECTIVES: This study sought to compare PVI durability and arrhythmia recurrence between pulsed field ablation (PFA) and radiofrequency ablation (RFA) in persistent AF patients. METHODS: Persistent AF patients undergoing PVI were prospectively enrolled, with a mandatory remapping procedure performed after 6 months regardless of recurrence. RFA was used in phase 1 (n = 30) and PFA was used in phase 2 (n = 30). Patients were followed with 7-day Holter electrocardiograms after 3, 6, and 12 months. Primary and secondary endpoints were PVI durability and arrhythmia recurrence. RESULTS: Of 60 enrolled patients, 51 underwent the mandated remapping procedure after a median of 7.2 months (mean age 68 years; 82% male). PVI was durable in 78 of 102 PVs (76%) with RFA and in 82 of 104 PVs (79%) with PFA (adjusted OR: 1.20; 95% CI: 0.37-3.88; P = 0.77), with lowest durability in the right superior PV (PFA 72%; RFA 69%). All PVs were durably isolated in 26 patients (51%). Of 26 patients (51%) with durably isolated PVs, 9 (35%) experienced AF recurrence prior to the remapping procedure. Of 25 patients (49%) with reconnected PVs, 7 (28%) experienced AF recurrence. At 1-year follow-up, freedom from recurrence after mandated redo procedure was 70% with no difference between the 2 ablation technologies (adjusted HR: 0.80; 95% CI: 0.24-2.64; P = 0.71). CONCLUSIONS: In patients with persistent AF, PFA demonstrated PVI durability comparable to RFA. Arrhythmia recurrence occurred in a substantial proportion of patients with durable PVI, suggesting a role for non-PV mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: Laurent.Roten@insel.ch.
Förderung
- Biosense Webster Inc
Zitieren
APA
Galuszka, O. M., Kueffer, T., Baldinger, S. H., Servatius, H., Siklódy, C. H., Kozhuharov, N., Thalmann, G., Madaffari, A., Haeberlin, A., Noti, F., Tanner, H., Reichlin, T., & Roten, L. (2026). PVI Durability After PFA or RFA in Persistent-AF. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2026.04.027
Vancouver
Galuszka OM, Kueffer T, Baldinger SH, Servatius H, Siklódy CH, Kozhuharov N, et al. PVI Durability After PFA or RFA in Persistent-AF. JACC: Clinical Electrophysiology. 2026. doi:10.1016/j.jacep.2026.04.027
BibTeX
@article{Galuszka2026,
author = {Galuszka, Oskar M and Kueffer, Thomas and Baldinger, Samuel H and Servatius, Helge and Siklódy, Claudia Herrera and Kozhuharov, Nikola and Thalmann, Gregor and Madaffari, Antonio and Haeberlin, Andreas and Noti, Fabian and Tanner, Hildegard and Reichlin, Tobias and Roten, Laurent},
title = {PVI Durability After PFA or RFA in Persistent-AF},
journal = {JACC: Clinical Electrophysiology},
year = {2026},
doi = {10.1016/j.jacep.2026.04.027}
}
EUVIMED